Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Protara Therapeutics, Inc. (TARA) had Return on Equity of -17.05% for the most recently reported fiscal year, ending 2020-12-31.
| Income Statement Financials | |
-- |
|
$-33.98M |
|
-- |
|
-- |
|
$34.44M |
|
$-34.44M |
|
$0.47M |
|
$-33.98M |
|
$-33.98M |
|
$-33.98M |
|
$-33.98M |
|
$-33.98M |
|
$-33.98M |
|
$-34.44M |
|
$-34.25M |
|
7.23M |
|
7.23M |
|
$-4.70 |
|
$-4.70 |
|
| Balance Sheet Financials | |
$169.44M |
|
$1.24M |
|
$33.72M |
|
$203.16M |
|
$2.92M |
|
-- |
|
$1.00M |
|
$3.91M |
|
$199.24M |
|
$169.73M |
|
$199.24M |
|
11.21M |
|
| Cash Flow Statement Financials | |
$-23.41M |
|
$2.83M |
|
$189.40M |
|
$0.56M |
|
$169.39M |
|
$168.83M |
|
$9.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
58.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-17.05% |
-20.02% |
|
-16.73% |
|
-17.05% |
|
$17.77 |
|
$-3.36 |
|
$-3.24 |
|